Day 1, Session IV

Early-Stage Diagnostic Devices and Product Pipeline: New Concepts and Initial Findings, moderated by Daniel Friedman, MD, Assistant Professor of Neurology, New York University

 

This 6 presentations and panel session includes:

  • Cyberonics | ProGuardian RestTM | An innovative, In-Home Device Systems Designed to Monitor, Detect, and Log Night-time Seizure Activity
    Laurie Groven, Global Medical Device / Diagnostic Marketing and Sales Executive, Cyberonics
    Starts at 1:22
     
  • Brain Sentinel | EMG Based Convulsive Seizure Detection and Warning System
    Jose E. Cavazos, MD, PhD, VP, Medical Affairs, Brain Sentinel, LGCH, Inc.
    Starts at 12:00
     
  • Epitel, Inc. | Wireless EEG Patch
    Mark Lehmkuhle, PhD, CEO, CTO, Epitel, Inc.
    Starts at 24:44
     
  • Empatica | Embrace: Autonomic and Seizure Events -- Personalized Monitoring and Alerts
    Rosalind W. Picard, Sc.D., Empatica, Inc. and MIT Media Lab
    Starts at 33:15
     
  • Smart Monitor | Automated Seizure Tracking and Recording
    Anoo Nathan, CEO, Smart Monitor
    Starts at 44:55
     
  • RTI International | ESAP
    Kristin H. Gilchrist, PhD, Research Scientist Electronics and Applied Physics Division, RTI International
    Starts at 52:42
     
  • Panel session: Seizure Detection and Alerting Devices, Are They Ready for Prime Time?
    Moderator: Daniel Friedman, MD
    Assistant Professor of Neurology, NYU, Comprehensive Epilepsy Center
    Starts at 1:00:05
     

<<Previous Video:
Day 1, Early-Stage Drug Pipeline: Proof of Principle through IND

>>Next Video:
Day 1, Late-Stage and Approved Devices--What is New?, Nonprofit Organization, Government and Crowdfunding--Grants, Awards and Funding to Advance Research to the Next Critical Stage, Lifetime Accelerator Award

ADVERTISEMENT
2014 Epilepsy Pipeline Conference

On June 5-7, 2014 in San Francisco, CA, the Epilepsy Therapy Project, an initiative of the Epilepsy Foundation presented the 4th Biennial Epilepsy Pipeline Conference 2014, held at the Hyatt Regency, San Francisco.

Showcasing the most promising epilepsy therapies from healthcare companies dedicated to pioneering and advancing drugs, biologics, technologies and devices for epilepsy and seizures, this year's conference featured the third annual "Shark Tank" competition, in addition to a day designated for people with epilepsy, families and advocates. The conference brought together decision-makers with a stake in the field of epilepsy treatment, therapeutic innovation and product development. Speakers and attendees included emerging biotech and medical technology companies, major pharmaceutical and device companies, and researchers and innovators at the cutting-edge of epilepsy and CNS treatment advances.

Read the press release for more information

ADVERTISEMENT